High-Resolution Solid-State Manometry of the Effect of Succinylcholine on Barrier Pressure

Sponsor
China-Japan Friendship Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05556408
Collaborator
(none)
14
1
10

Study Details

Study Description

Brief Summary

The lower esophageal sphincter(LES)plays a key role in preventing regurgitation and aspiration. The pressure of LES partly comes from striated muscles derived from the crural portion of the diaphragm. The effect of succinylcholine on esophagogastric junction during anesthesia induction is not clear. We conducted a prospective interventional study on the effect of succinylcholine on the barrier pressure (BrP) of the esophagogastric junction.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

14 patients participated in the study. Propofol and succinylcholine were used for anesthesia induction. High-resolution solid-state manometry (HRM) was used to monitor the changes of the LES pressure and the intragastric pressure (IGP).The administration of propofol could significantly increase the LES pressure during end expiration and during inspiration. The application of succinylcholine had no effect on the LES pressure during end expiration, but significantly reduced the LES pressure during inspiration. Propofol had no effect on BrP. After the application of succinylcholine, BrP decreased significantly during inspiration.

Propofol significantly increased the LES pressure. Succinylcholine significantly reduced the pressure of LES and BrP during inspiration.

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
High-Resolution Solid-State Manometry of the Effect of Succinylcholine on Barrier Pressure
Actual Study Start Date :
Mar 1, 2015
Actual Primary Completion Date :
Dec 30, 2015
Actual Study Completion Date :
Dec 30, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: High-Resolution Solid-State Manometry

Before catheterization, the patients were monitored by pulse oximetry, electrocardiogram, automatic noninvasive arterial blood pressure and bispectral index (BIS). Before the insertion of the manometric catheter an intravenous cannula was inserted. The manometric catheter was placed through the nose until the pressure from the lower esophageal sphincter to the stomach could be recorded. After confirming the position of the catheter, the catheter was taped to the nose.

Drug: Succinylcholine
1.5mg/kg was given intravenously
Other Names:
  • propofol
  • Outcome Measures

    Primary Outcome Measures

    1. pressure of lower esophageal sphincter [15 minutes]

      On the isocontour plots, the esophageal sphincter can be located as abrupt transitions in the pressure pattern (Fig. 2). The proximal edge of the LES was defined by sudden transition to the intra-esophageal pressure, and the distal edge was defined by sudden transition to the IGP. The pressure of the LES measured during end expiration was defined as the pressure of intrinsic sphincter to avoid the influence from the rural component of the LES. The rural component of the LES was defined as the highest pressure point at the esophagogastric junction during inspiration.

    2. pressure of intragastric [15 minutes]

      IGP was measured at 2 cm below the crural diaphragmatic component of the LES

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Exclusion criteria:patients who classified as American Society of Anesthesiologists classification system (ASA) II were included. Patients were included in the study if they had on history of diabetes, pharynx and digestive diseases.

    Exclusion criteria:currently pregnant or breastfeeding, a body mass index (BMI) over 30 kg/m2. All patients underwent preoperative preparation according to clinical routine and did not give preoperative drugs.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • China-Japan Friendship Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yanting Cao, PhD, China-Japan Friendship Hospital
    ClinicalTrials.gov Identifier:
    NCT05556408
    Other Study ID Numbers:
    • the Effect of Succinylcholine
    First Posted:
    Sep 27, 2022
    Last Update Posted:
    Sep 27, 2022
    Last Verified:
    Sep 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yanting Cao, PhD, China-Japan Friendship Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 27, 2022